Jonathan Webster
Johns Hopkins University
H-index: 16
North America-United States
Top articles of Jonathan Webster
AMPK inhibition sensitizes acute leukemia cells to BH3 mimetic-induced cell death
Cell Death & Differentiation
2024/3/27
Outcome heterogeneity of TP53-mutated myeloid neoplasms and the role of allogeneic hematopoietic cell transplantation
Haematologica
2024/3/3
A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia
Cancer medicine
2023/12
Bijal Shah
H-Index: 6
Jonathan Webster
H-Index: 10
Blinatumomab in Combination with Immune Checkpoint Inhibitors (ICIs) of PD-1 and CTLA-4 in Adult Patients with Relapsed/Refractory (R/R) CD19 Positive B-Cell Acute …
Blood
2023/11/28
A Phase IB/II Study of Blinatumomab in Patients with B-Cell Acute Lymphoblastic Leukemia (ALL) and B-Cell Non-Hodgkin Lymphoma (NHL) As Post-Allogeneic Blood or Marrow …
Blood
2023/11/28
A Phase I Trial of Activated Donor-Derived Marrow Infiltrating Lymphocytes to Treat Relapsed Hematologic Malignancies after Allogeneic Transplantation with Post-Transplantation …
Blood
2023/11/28
This CAR won’t start: predicting nonresponse in ALL
Blood Advances
2023/8/8
P375: INOTUZUMB OZOGAMICIN PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPSED OR REFRACTORY ACUTE B-LYMPHOBLASTIC LEUKEMIA
HemaSphere
2023/8/1
Chiara Sartor
H-Index: 7
Alessandro Bruno
H-Index: 8
Jonathan Webster
H-Index: 10
Francesco Restuccia
H-Index: 0
DNA methyltransferase inhibitor exposure–response: Challenges and opportunities
2023/8
Detection of an atypical BCR:: ABL1 fusion in a patient with secondary B-cell acute lymphoblastic leukemia/lymphoma following multiple myeloma treatment
Cancer Genetics
2023/6/1
Jonathan Webster
H-Index: 10
Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease
Leukemia & Lymphoma
2023/3/21
Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age≥ 55 Years
Transplantation and cellular therapy
2023/3/1
Allogeneic Blood or Marrow Transplantation (AlloBMT) with High-Dose Post-Transplantation Cyclophosphamide (PTCy) for Acute Lymphoblastic Leukemia (ALL) in Patients Aged≥ 55 …
Blood
2022/11/15
Impact of Inotuzumb Ozogamicin on Outcome in Relapsed or Refractory Acute B-Lymphoblastic Leukemia Patients Prior to Allogeneic Hematopoietic Stem Cell Transplantation
Blood
2022/11/15
Gemtuzumab Ozogamicin for Cytoreduction in Hyperleukocytosis
Blood
2022/11/15
Jonathan Webster
H-Index: 10
Matthew Newman
H-Index: 6
Tania Jain
H-Index: 15
William Brian Dalton
H-Index: 13
Outcomes of Patients with TP53-Mutated Myeloid Neoplasms (TP53-MN) and the Role of Allogenic Blood or Marrow Transplantation (alloBMT)
Blood
2022/11/15
Jonathan Webster
H-Index: 10
Tania Jain
H-Index: 15
William Brian Dalton
H-Index: 13
Richard J Jones
H-Index: 54
ALL-269 Safety and Pharmacokinetics of Calaspargase Pegol in Adults With Newly Diagnosed Philadelphia-Negative Acute Lymphoblastic Leukemia: A Phase 2/3 Study
Clinical Lymphoma Myeloma and Leukemia
2022/10/1
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and BCR-ABL-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving …
Haematologica
2022/9/9
Chiara Sartor
H-Index: 7
Jonathan Webster
H-Index: 10
Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy
Leukemia & lymphoma
2022/7/3
Theodoros Karantanos
H-Index: 22
Jonathan Webster
H-Index: 10
Ravi Varadhan
H-Index: 38
Richard J Jones
H-Index: 54
Tania Jain
H-Index: 15
Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis with nonmyeloablative conditioning for blood or marrow transplantation for myelofibrosis
Transplantation and cellular therapy
2022/5/1
Co-Authors
